Clinical Trial: Comparison of Intravitreal Bevacizumab Injection with Combination of Suprachoroidal Triamcinolone Acetonide Along with Intravitreal Bevacizumab Injection in the Treatment of Diabetic Macular Edema in Pseudophakic Patients

U.S., March 19 -- ClinicalTrials.gov registry received information related to the study (NCT06882551) titled 'Comparison of Intravitreal Bevacizumab Injection with Combination of Suprachoroidal Triamcinolone Acetonide Along with Intravitreal Bevacizumab Injection in the Treatment of Diabetic Macular Edema in Pseudophakic Patients' on Nov. 10, 2024.

Brief Summary: Patients were included in the study who were pseudophakic with center-involved (sub-foveal) diabetic macular edema

Study Start Date: April 01, 2023

Study Type: INTERVENTIONAL

Condition: Diabetic Macular Edema (DME)

Intervention: DRUG: Intravitreal Bevacizumab IVB

Intravitreal bevacizumab alone

DRUG: intravitreal bevacizumab and suprachoroidal triamcinolone acetonide

Combi...